Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harvard Bioscience (HBIO) Income from Continuing Operations (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Income from Continuing Operations for 16 consecutive years, with 1231000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations rose 74.31% to 1231000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 67038000.0, a 378.88% decrease, with the full-year FY2024 number at 12095000.0, down 279.51% from a year prior.
  • Income from Continuing Operations was 1231000.0 for Q3 2025 at Harvard Bioscience, up from 2328000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 2435000.0 in Q2 2022 to a low of 50294000.0 in Q1 2025.
  • A 5-year average of 4742368.42 and a median of 1629000.0 in 2022 define the central range for Income from Continuing Operations.
  • Biggest YoY gain for Income from Continuing Operations was 693.9% in 2022; the steepest drop was 1902.94% in 2022.
  • Harvard Bioscience's Income from Continuing Operations stood at 590000.0 in 2021, then tumbled by 376.1% to 1629000.0 in 2022, then fell by 0.31% to 1634000.0 in 2023, then crashed by 706.92% to 13185000.0 in 2024, then skyrocketed by 90.66% to 1231000.0 in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Income from Continuing Operations are 1231000.0 (Q3 2025), 2328000.0 (Q2 2025), and 50294000.0 (Q1 2025).